Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015–2018 Years

BACKGROUND: In Poland drug programmes developed by the Minister of Health and financed by the National Health Fund are special reimbursement frameworks of innovative, expensive, and mostly hospital based medical products used for a small number of patients. RESEARCH DESIGN: The research presented in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mela, Aneta, Poniatowski, Łukasz A., Drop, Bartłomiej, Furtak-Niczyporuk, Marzena, Jaroszyński, Janusz, Wrona, Witold, Staniszewska, Anna, Dąbrowski, Jan, Czajka, Anna, Jagielska, Beata, Wojciechowska, Monika, Niewada, Maciej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456857/
https://www.ncbi.nlm.nih.gov/pubmed/32922285
http://dx.doi.org/10.3389/fphar.2020.01123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456857/
https://www.ncbi.nlm.nih.gov/pubmed/32922285
http://dx.doi.org/10.3389/fphar.2020.01123

Ejemplares similares